Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukemia, Large Granular Lymphocytic | 6 | 2018 | 24 | 0.750 |
Why?
|
Leukemia, Myeloid, Acute | 8 | 2024 | 3610 | 0.660 |
Why?
|
Quinazolinones | 1 | 2016 | 221 | 0.470 |
Why?
|
Purines | 1 | 2016 | 609 | 0.420 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2018 | 1605 | 0.390 |
Why?
|
STAT3 Transcription Factor | 4 | 2018 | 872 | 0.370 |
Why?
|
STAT5 Transcription Factor | 3 | 2016 | 266 | 0.340 |
Why?
|
Antineoplastic Agents | 7 | 2024 | 13632 | 0.330 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 1549 | 0.280 |
Why?
|
Drug Resistance, Neoplasm | 6 | 2018 | 5301 | 0.250 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2019 | 380 | 0.230 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 1 | 2024 | 84 | 0.220 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2024 | 310 | 0.220 |
Why?
|
Leukemia, Megakaryoblastic, Acute | 1 | 2023 | 48 | 0.210 |
Why?
|
Drug Screening Assays, Antitumor | 4 | 2018 | 714 | 0.210 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2020 | 1783 | 0.200 |
Why?
|
Mutation | 15 | 2020 | 30004 | 0.190 |
Why?
|
Genes, T-Cell Receptor | 1 | 2020 | 29 | 0.190 |
Why?
|
Janus Kinases | 2 | 2018 | 249 | 0.170 |
Why?
|
Chromosome Deletion | 1 | 2024 | 1386 | 0.160 |
Why?
|
Tandem Repeat Sequences | 1 | 2018 | 180 | 0.150 |
Why?
|
fms-Like Tyrosine Kinase 3 | 2 | 2018 | 496 | 0.150 |
Why?
|
Leukemia, Prolymphocytic, T-Cell | 1 | 2017 | 23 | 0.140 |
Why?
|
Mutation, Missense | 3 | 2015 | 2567 | 0.140 |
Why?
|
Tumor Cells, Cultured | 4 | 2018 | 6125 | 0.140 |
Why?
|
High-Throughput Screening Assays | 3 | 2017 | 929 | 0.140 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2020 | 548 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2023 | 1404 | 0.130 |
Why?
|
Lymphoma, B-Cell | 1 | 2023 | 938 | 0.130 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2016 | 77 | 0.130 |
Why?
|
src Homology Domains | 2 | 2015 | 361 | 0.130 |
Why?
|
Rad51 Recombinase | 1 | 2016 | 189 | 0.120 |
Why?
|
Genes, Homeobox | 1 | 2016 | 285 | 0.120 |
Why?
|
Drug Resistance, Multiple | 1 | 2016 | 255 | 0.120 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 686 | 0.120 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2016 | 123 | 0.120 |
Why?
|
Receptor, EphA7 | 1 | 2014 | 7 | 0.120 |
Why?
|
Cytarabine | 1 | 2016 | 697 | 0.120 |
Why?
|
Drug Synergism | 1 | 2018 | 1756 | 0.120 |
Why?
|
Mycobacterium Infections | 1 | 2014 | 122 | 0.110 |
Why?
|
Arthritis, Rheumatoid | 2 | 2020 | 3753 | 0.110 |
Why?
|
Sezary Syndrome | 1 | 2014 | 80 | 0.110 |
Why?
|
Clone Cells | 1 | 2016 | 1668 | 0.110 |
Why?
|
Agammaglobulinemia | 1 | 2014 | 172 | 0.110 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2016 | 651 | 0.100 |
Why?
|
Tamoxifen | 1 | 2016 | 965 | 0.100 |
Why?
|
Decision Support Techniques | 1 | 2021 | 2004 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2020 | 2058 | 0.090 |
Why?
|
Cell Line, Tumor | 5 | 2023 | 16954 | 0.090 |
Why?
|
Small Molecule Libraries | 1 | 2016 | 731 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2020 | 4373 | 0.090 |
Why?
|
Patient Care Team | 1 | 2021 | 2515 | 0.090 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 382 | 0.090 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2011 | 239 | 0.090 |
Why?
|
Genetic Diseases, Inborn | 1 | 2014 | 603 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 855 | 0.080 |
Why?
|
Finland | 2 | 2021 | 607 | 0.080 |
Why?
|
Endometrial Neoplasms | 1 | 2018 | 1366 | 0.080 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 4739 | 0.070 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1743 | 0.070 |
Why?
|
bcl-X Protein | 2 | 2023 | 410 | 0.070 |
Why?
|
Aniline Compounds | 3 | 2018 | 1073 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2020 | 3025 | 0.070 |
Why?
|
Glucocorticoids | 1 | 2016 | 2159 | 0.070 |
Why?
|
Gene Expression Profiling | 6 | 2020 | 9417 | 0.070 |
Why?
|
Cytokines | 1 | 2020 | 7386 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2915 | 0.060 |
Why?
|
Humans | 30 | 2024 | 761222 | 0.060 |
Why?
|
T-Lymphocytes | 2 | 2020 | 10203 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3594 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8457 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2016 | 8531 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 3163 | 0.050 |
Why?
|
Sulfonamides | 3 | 2018 | 1977 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2014 | 2974 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2014 | 3446 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2244 | 0.050 |
Why?
|
Disease Progression | 2 | 2016 | 13511 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 4251 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2018 | 4872 | 0.050 |
Why?
|
Complementarity Determining Regions | 1 | 2020 | 149 | 0.040 |
Why?
|
Male | 14 | 2021 | 360703 | 0.040 |
Why?
|
Blast Crisis | 1 | 2020 | 102 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5783 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2016 | 20982 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2020 | 370 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11733 | 0.040 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2020 | 430 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2020 | 874 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 2024 | 0.040 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2017 | 68 | 0.040 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2017 | 70 | 0.040 |
Why?
|
Adult | 8 | 2020 | 221120 | 0.040 |
Why?
|
Bone Marrow | 2 | 2018 | 2911 | 0.040 |
Why?
|
Gene Deletion | 2 | 2016 | 2658 | 0.040 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2020 | 800 | 0.030 |
Why?
|
3T3 Cells | 1 | 2018 | 1083 | 0.030 |
Why?
|
Protein Structure, Tertiary | 2 | 2014 | 3778 | 0.030 |
Why?
|
Quinacrine | 1 | 2016 | 24 | 0.030 |
Why?
|
STAT Transcription Factors | 1 | 2017 | 189 | 0.030 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 470 | 0.030 |
Why?
|
Keratin-5 | 1 | 2016 | 45 | 0.030 |
Why?
|
Keratin-18 | 1 | 2016 | 38 | 0.030 |
Why?
|
Naphthoquinones | 1 | 2016 | 58 | 0.030 |
Why?
|
Middle Aged | 10 | 2021 | 220858 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2020 | 22174 | 0.030 |
Why?
|
Oxazoles | 1 | 2017 | 199 | 0.030 |
Why?
|
Aged | 9 | 2020 | 169292 | 0.030 |
Why?
|
Tetrahydronaphthalenes | 1 | 2016 | 86 | 0.030 |
Why?
|
Remission Induction | 1 | 2021 | 2392 | 0.030 |
Why?
|
WT1 Proteins | 1 | 2016 | 184 | 0.030 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 428 | 0.030 |
Why?
|
Genomics | 1 | 2011 | 5829 | 0.030 |
Why?
|
beta 2-Microglobulin | 1 | 2016 | 329 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2813 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4574 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2018 | 380 | 0.030 |
Why?
|
Microsatellite Instability | 1 | 2019 | 716 | 0.030 |
Why?
|
Kallikreins | 1 | 2016 | 220 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2018 | 1334 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2016 | 407 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3634 | 0.030 |
Why?
|
Female | 12 | 2021 | 392552 | 0.030 |
Why?
|
Drugs, Investigational | 1 | 2016 | 212 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1553 | 0.030 |
Why?
|
Tretinoin | 1 | 2016 | 517 | 0.030 |
Why?
|
Apoptosis | 2 | 2023 | 9478 | 0.030 |
Why?
|
Multigene Family | 1 | 2016 | 1075 | 0.030 |
Why?
|
Blotting, Western | 1 | 2020 | 5032 | 0.030 |
Why?
|
Gene Expression | 2 | 2017 | 7571 | 0.020 |
Why?
|
Mice | 4 | 2023 | 81330 | 0.020 |
Why?
|
Genomic Instability | 1 | 2016 | 709 | 0.020 |
Why?
|
Cell Differentiation | 2 | 2023 | 11512 | 0.020 |
Why?
|
Dimerization | 1 | 2013 | 887 | 0.020 |
Why?
|
Base Composition | 1 | 2011 | 290 | 0.020 |
Why?
|
Drug Repositioning | 1 | 2013 | 233 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16575 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2017 | 1767 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4243 | 0.020 |
Why?
|
INDEL Mutation | 1 | 2011 | 265 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2016 | 961 | 0.020 |
Why?
|
Imidazoles | 1 | 2016 | 1172 | 0.020 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2016 | 937 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2014 | 1737 | 0.020 |
Why?
|
Thiazoles | 1 | 2017 | 1517 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 2016 | 1077 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6200 | 0.020 |
Why?
|
Genome, Human | 2 | 2013 | 4423 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2706 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2452 | 0.020 |
Why?
|
Cell Cycle | 1 | 2017 | 2926 | 0.020 |
Why?
|
Mutagenesis | 1 | 2013 | 1226 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10088 | 0.020 |
Why?
|
Paclitaxel | 1 | 2016 | 1730 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2013 | 7571 | 0.020 |
Why?
|
Adolescent | 4 | 2020 | 88300 | 0.020 |
Why?
|
Th17 Cells | 1 | 2014 | 794 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2018 | 58952 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9297 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 59222 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1852 | 0.020 |
Why?
|
Heterozygote | 1 | 2014 | 2778 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2011 | 2175 | 0.020 |
Why?
|
Animals | 4 | 2023 | 168089 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 3073 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2016 | 2465 | 0.020 |
Why?
|
Base Sequence | 1 | 2016 | 12404 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2014 | 2194 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6781 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10423 | 0.010 |
Why?
|
Sequence Analysis, RNA | 1 | 2012 | 2011 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2014 | 2726 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3777 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4111 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2012 | 2549 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2803 | 0.010 |
Why?
|
Signal Transduction | 2 | 2018 | 23419 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15841 | 0.010 |
Why?
|
Phosphorylation | 1 | 2013 | 8300 | 0.010 |
Why?
|
Genetic Variation | 1 | 2016 | 6567 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4744 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5665 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2014 | 3092 | 0.010 |
Why?
|
Cohort Studies | 2 | 2014 | 41496 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14392 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18384 | 0.010 |
Why?
|
Alleles | 1 | 2011 | 6857 | 0.010 |
Why?
|
Genetic Testing | 1 | 2013 | 3537 | 0.010 |
Why?
|
Computational Biology | 1 | 2011 | 3499 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6919 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2016 | 9567 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21366 | 0.010 |
Why?
|
Computer Simulation | 1 | 2011 | 6224 | 0.010 |
Why?
|
DNA | 1 | 2011 | 7189 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 12985 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18222 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 14675 | 0.010 |
Why?
|
Prospective Studies | 1 | 2017 | 54437 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15920 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 80675 | 0.010 |
Why?
|
Child | 1 | 2018 | 80154 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2013 | 64681 | 0.000 |
Why?
|